mitomycin has been researched along with Weight Loss in 10 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Between October 1986 and May 2002 all patients with inoperable pleural mesothelioma were considered for treatment with MVP (mitomycin C 8 mg/m2 every 6 weeks, vinblastine 6 mg/m2 every 3 weeks and cisplatin 50 mg/m2 every 3 weeks) chemotherapy." | 9.11 | The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma. ( Andreopoulou, E; Ashley, S; Eisen, T; Ford, HE; Norton, A; O'Brien, ME; Priest, K; Ross, PJ; Smith, IE, 2004) |
| "Between October 1986 and May 2002 all patients with inoperable pleural mesothelioma were considered for treatment with MVP (mitomycin C 8 mg/m2 every 6 weeks, vinblastine 6 mg/m2 every 3 weeks and cisplatin 50 mg/m2 every 3 weeks) chemotherapy." | 5.11 | The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma. ( Andreopoulou, E; Ashley, S; Eisen, T; Ford, HE; Norton, A; O'Brien, ME; Priest, K; Ross, PJ; Smith, IE, 2004) |
| "Deleterious oral mucositis (OM) develops during radiotherapy (RT) or chemoradiotherapy for head-and-neck cancer (HNC) patients." | 2.77 | Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer. ( Chung, YL; Jen, YM; Lin, YH; Wang, LW; Yen, SH, 2012) |
| "Weight loss was common after HIPEC as 38 of 41 patients demonstrated weight loss." | 1.43 | Feeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher readmission rates. ( Beaty, KA; Dineen, SP; Fournier, KF; Mansfield, PF; Rafeeq, S; Robinson, KA; Roland, CL; Royal, RE, 2016) |
| "Metastatic bronchioloalveolar carcinoma is an aggressive disease that is associated with a poor prognosis, similar to metastatic adenocarcinoma of the lung." | 1.28 | Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: comparison of clinical manifestations, chemotherapeutic responses, and prognosis. ( Eagan, RT; Feldman, ER; Schaid, DJ, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dineen, SP | 1 |
| Robinson, KA | 1 |
| Roland, CL | 1 |
| Beaty, KA | 1 |
| Rafeeq, S | 1 |
| Mansfield, PF | 1 |
| Royal, RE | 1 |
| Fournier, KF | 1 |
| Türkyilmaz, Z | 1 |
| Sönmez, K | 1 |
| Karabulut, R | 1 |
| Gülbahar, O | 1 |
| Poyraz, A | 1 |
| Sancak, B | 1 |
| Başaklar, AC | 1 |
| Yen, SH | 1 |
| Wang, LW | 1 |
| Lin, YH | 1 |
| Jen, YM | 1 |
| Chung, YL | 1 |
| Tebbutt, NC | 2 |
| Norman, A | 2 |
| Cunningham, D | 2 |
| Iveson, T | 1 |
| Seymour, M | 1 |
| Hickish, T | 1 |
| Harper, P | 1 |
| Maisey, N | 1 |
| Mochlinski, K | 1 |
| Prior, Y | 1 |
| Hill, M | 2 |
| Kelleher, M | 1 |
| Andreyev, J | 1 |
| Allen, M | 1 |
| Andreopoulou, E | 1 |
| Ross, PJ | 1 |
| O'Brien, ME | 1 |
| Ford, HE | 1 |
| Priest, K | 1 |
| Eisen, T | 1 |
| Norton, A | 1 |
| Ashley, S | 1 |
| Smith, IE | 1 |
| Feldman, ER | 1 |
| Eagan, RT | 1 |
| Schaid, DJ | 1 |
| Fumagalli, U | 1 |
| Trabucchi, E | 1 |
| Soligo, M | 1 |
| Rosati, R | 1 |
| Rebuffat, C | 1 |
| Tonelli, C | 1 |
| Montorsi, M | 1 |
| Takagami, S | 1 |
| Nishiyama, M | 1 |
| Kim, R | 1 |
| Kirihara, Y | 1 |
| Jinushi, K | 1 |
| Saeki, K | 1 |
| Saeki, T | 1 |
| Nosoh, Y | 1 |
| Niimoto, M | 1 |
| Hattori, T | 1 |
| Allum, WH | 1 |
| Hallissey, MT | 1 |
| Kelly, KA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Double Lung Transplant REgistry Aimed for Lung-limited Malignancies (DREAM) - a Prospective Observational Registry Study for Patients Undergoing Lung Transplantation for Medically Refractory Cancers Confined to the Lungs[NCT05671887] | 125 participants (Anticipated) | Observational [Patient Registry] | 2022-11-16 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for mitomycin and Weight Loss
| Article | Year |
|---|---|
Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Double-Blind Method; E | 2012 |
A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 2002 |
Mitomycin C, carboplatin and protracted venous infusion 5-fluorouracil in advanced oesophago-gastric and pancreatic cancer: results of two phase II studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Esophageal Neoplasms; Fema | 2003 |
The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; | 2004 |
Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy | 1989 |
5 other studies available for mitomycin and Weight Loss
| Article | Year |
|---|---|
Feeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher readmission rates.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Canc | 2016 |
Mitomycin C decreases the rate of stricture formation in caustic esophageal burns in rats.
Topics: Administration, Topical; Alkalies; Animals; Antibiotics, Antineoplastic; Burns, Chemical; Disease Mo | 2009 |
Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: comparison of clinical manifestations, chemotherapeutic responses, and prognosis.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Age Factors; Aged; Antineoplastic Combin | 1992 |
Effects of intraperitoneal chemotherapy on anastomotic healing in the rat.
Topics: Anastomosis, Surgical; Animals; Hydroxyproline; Injections, Intraperitoneal; Injections, Intravenous | 1991 |
[Comparative study on the anticancer activities of KW2149 and mitomycin C against human tumor xenografts using subrenal capsule assay].
Topics: Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Humans; Mice; Mice, Inbred Strains; Mitomyc | 1989 |